Hospinnomics

What Hospinnomics does

Hospinnomics is a non-commercial academic research chair in health economics, jointly established in 2014 by Assistance Publique-Hôpitaux de Paris (AP-HP), Europe's largest university hospital system, and Paris School of Economics (PSE), a leading economics research institution. The chair operates from Hôtel-Dieu in central Paris under the scientific direction of Lise Rochaix (Professor at PSE and University Paris 1 Panthéon-Sorbonne), with a permanent team of approximately 6 members supported by PhD students, postdoctoral researchers, and master's interns totaling 11-15 members. Its research is organized around two dimensions: Methods (ME) focusing on health technology assessment and organizational evaluation methodologies, and Regulation (RE) analyzing healthcare production and allocation from efficiency and equity perspectives.

The chair conducts applied health economics research using advanced methodologies including econometrics, health technology assessment, behavioral economics, and policy evaluation. Its technology stack leverages access to AP-HP administrative databases, national health data (SNDS), DREES data, IMS pharmaceutical data, and cohort data (CONSTANCES, GAZEL) for empirical research on hospital payment schemes, drug pricing, healthcare organization, and patient pathway optimization. The chair maintains 15+ ongoing research projects covering topics such as Article 51 LFSS financing experiments, cancer screening (CBIG-SCREEN), rare cancers (OPTISARC), stroke care optimization (BOOSTER), genomic platform evaluation (SEQOGEN), and social robots in geriatric care (ROSIE). Outputs include peer-reviewed publications, 16+ Recto-Verso policy briefs, book chapters, and a MOOC in health economics launched in 2017.

The chair does not sell products or services. Its funding comes from institutional partnerships with AP-HP and PSE, supplemented by research grants from French Ministry of Health, INCa (National Cancer Institute), IRESP (Institut de Recherche en Santé Publique), CNAMTS (National Health Insurance Fund), DGOS, and the IMAGINE Foundation. Activities are disseminated through open-access publications, a bi-monthly newsletter, annual conferences, technical workshops (Atelier Technique Médicaments), and seminars, all provided free of charge to the public, healthcare decision-makers, and the academic community.

Name

Hospinnomics

Legal name

Hospinnomics - Hospital Innovation Economics

Website

https://hospinnomics.eu

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Hospinnomics is a French academic research chair in health economics, jointly founded in 2014 by AP-HP and Paris School of Economics. It conducts applied research on hospital organization, drug pricing, and healthcare policy for French government stakeholders.

Ownership category

akta.pro rank

Product category

Health Economics Research

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

Keywords

• Health economics research
• Health technology assessment
• Hospital payment evaluation
• Drug pricing research
• Healthcare policy analysis

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Institutional Partnership Funding: Hospinnomics is funded through institutional partnerships with AP-HP (Assistance Publique-Hôpitaux de Paris) and PSE - Ecole d'économie de Paris (Paris School of Economics). These founding partners provide core operational and research funding.
2. Research Grants and Project Funding: The chair receives dedicated research funding from public sources including French Ministry of Health, INCa (National Cancer Institute), IRESP (Institut de Recherche en Santé Publique), CNAMTS (National Health Insurance Fund), DGOS, and IMAGINE Foundation. Funding supports specific research projects in health economics.
3. Doctoral and Postdoctoral Training: The chair hosts doctoral students, postdoctoral researchers, and master's interns, with some positions funded by external grants (e.g., Imagine Institute, PSE Enterprise and Society partnership).

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Hospinnomics is an academic research chair that conducts health economics research, policy evaluation, and health technology assessment to inform hospital organization, drug pricing, and healthcare delivery decisions. It produces empirical research, policy briefs, academic publications, and training programs (including a MOOC and PhD/postdoctoral positions) for healthcare decision-makers, regulators, and the academic community, free of charge under its non-commercial research model.

Product overview

Hospinnomics is a health economics research chair established by AP-HP and Paris School of Economics in 2014. It is not a commercial product company but rather an academic research institution. Its offerings include research projects focused on hospital economics, healthcare regulation, and health technology assessment; a MOOC in health economics; Policy Briefs (Recto-Verso) for disseminating research; scientific publications (articles, reports, book chapters); the Atelier Médicaments workshop series; and various training and student exchange programs.

Differentiator

Problem solved

Functional benefit

Products and services

• MOOC in Health Economics A Massive Open Online Course providing education in health economics to students and professionals, launched in 2017.
• Atelier Médicaments (Drug Workshop) A forum for presentation and discussion between health economists and decision-makers on drugs and medical devices, held periodically at Hôtel-Dieu Paris.
• Training Programs Courses, teaching modules, student internships, scholarships, and international researcher exchanges on health economics topics, including PhD and postdoctoral training.
• Recto-Verso Policy Briefs A collection of two-page policy briefs making health economics research accessible to a broader audience of healthcare decision-makers and the public.
• Scientific Publications Academic articles, book chapters, and reports published by Hospinnomics researchers and affiliated scholars in peer-reviewed journals.
• Research Chair Activities (Health Economics Research and Policy Evaluation) A health economics research service conducting academic research, organizing seminars and conferences, publishing policy briefs, and providing training for healthcare decision-makers and the academic community.

Quantifiable outcome

• Online appointment booking tool at AP-HP increased realized appointments by 6.6% in user services
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Assistance Publique-Hôpitaux de Paris (AP-HP)coreStrategic or Co-development Partner · 1 January 2014AP-HP is the co-founding institutional partner of Hospinnomics. As France's largest hospital system (38 hospitals in Île-de-France), AP-HP provides research data access, clinical expertise, and real-world healthcare settings for economic evaluations. The partnership was initiated under Martin Hirsch, then Director of AP-HP, who sought to create an academic health economics structure to document organizational and investment decisions.
• PSE - Ecole d'économie de Paris (Paris School of Economics)coreStrategic or Co-development Partner · 1 January 2014PSE is the co-founding academic partner of Hospinnomics. Led by Pierre-Yves Geoffard, PSE contributes academic rigor, research infrastructure, doctoral programs, and connections to the international economics research community. The partnership aims to bridge academic economics research with healthcare policy decision-making.
• Institut National du Cancer (INCa)coreStrategic or Co-development PartnerINCa partners with Hospinnomics on cancer-related research including rare cancers and orphan drugs (OPTISARC project), pediatric oncology platforms (ME32), and cancer screening programs (CBIG-SCREEN). Joint work addresses innovation and inequality in cancer treatment and pharmaceutical market analysis.
• Haute Autorité de Santé (HAS)minorStrategic or Co-development PartnerHAS collaborates with Hospinnomics researchers on health technology assessment methodology, drug pricing evaluations, and comparative effectiveness research. Several publications involve HAS staff including Catherine Rumeau-Pichon and Véronique Raimond.
• Agence Technique de l'Information sur l'Hospitalisation (ATIH)minorStrategic or Co-development PartnerATIH collaborates on hospital payment scheme evaluations, risk adjustment modeling, and the ATIH drug survey (Enquête médicament ATIH). Hospinnomics researchers work with ATIH on innovative financing experiments under Article 51 LFSS.
• Caisse Nationale d'Assurance Maladie (CNAM / CNAMTS)minorStrategic or Co-development PartnerCNAMTS funded the case management for professional injuries project (RE22) for 3 years. The National Health Insurance Fund provides data access and co-funds research on hospital payment schemes and care pathways.
• IMAGINE Institute (Hôpital Necker, AP-HP)minorStrategic or Co-development PartnerThe IMAGINE Foundation at Hôpital Necker (AP-HP) provides 3-year doctoral funding for research on rare diseases (Setti Raïs' thesis), focusing on diagnostic and treatment access inequalities for genetic rare diseases.
• IRDES (Institut de Recherche et Documentation en Économie de la Santé)minorStrategic or Co-development PartnerIRDES researchers including Paul Dourgnon and Zeynep Or collaborate with Hospinnomics on health economics research, hospital performance measurement, and social protection studies. Joint publications and co-authorship on healthcare access and inequality topics.
• AGEPS (Agence Générale des Equipements et Produits de Santé, AP-HP)minorStrategic or Co-development PartnerAGEPS, the central procurement agency of AP-HP, collaborates on drug pricing research. Researchers including Albane Degrassat-Théas, Pascal Paubel, and François Bocquet participate in Hospinnomics' drug pricing working group, providing access to hospital pharmaceutical purchasing data.
• Imperial College London (Business School)minorStrategic or Co-development PartnerMarisa Miraldo, Associate Professor at Imperial College Business School, served as a Hospinnomics invited researcher in 2014 and has co-authored multiple publications with the chair. Eliana Barrenho was affiliated with Imperial College before moving to the OECD.
• London School of Economics (LSE)minorStrategic or Co-development PartnerMatteo Galizzi (LSE) was an invited Hospinnomics researcher in 2014-2015, contributing to the data linkage project (ME24). Mattéo Galizzi organizes reading groups and contributes to behavioral economics research in health.
• Gérond'if (Gérond'if EPS)minorStrategic or Co-development PartnerHospinnomics collaborates with Gérond'if on the ROSIE project (Robots sociaux et expérimentations en gériatrie), developing methodology to evaluate the individual and collective value of social robots in care pathways, in collaboration with CHU de Lille.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Others

• Haute Autorité de Santé (HAS): French health technology assessment and clinical guidelines authority that consumes Hospinnomics' research outputs; an adjacent ecosystem partner rather than a research peer, but central to the demand for Hospinnomics' evidence.
• European Observatory on Health Systems and Policies: WHO-hosted partnership producing comparative health systems and policy research across Europe; an adjacent ecosystem actor whose evidence-based policy work intersects with Hospinnomics' research themes.

Direct peers

• IRDES (Institut de Recherche et Documentation en Économie de la Santé): France's leading independent health economics and policy research institute, producing evidence on hospital performance, health insurance, and access to care — directly comparable mission and French policy focus to Hospinnomics.
• RAND Health: US-based health research division producing rigorous empirical evaluations of healthcare delivery, financing, and policy — a methodological peer in applied health economics and policy evaluation.
• Institute of Health Economics (IHE) Alberta: Canadian health economics and policy research institute producing HTA, drug reimbursement analyses, and hospital-finance research with a similar applied, decision-maker-facing orientation.
• Centre for Health Economics, University of York (CHE): One of the UK's premier academic health economics research centers, conducting HTA, econometric evaluation, and policy-relevant research with comparable methods and outputs to Hospinnomics.
• LSE Health: Health policy and economics research center at the London School of Economics; collaborates with Hospinnomics (e.g., Matteo Galizzi) and operates a comparable academic health-economics research model.
• Centre for Health Economics and Policy Analysis (CHEPA), McMaster University: Academic health economics and policy research center focused on HTA, financing, and equity — directly comparable in scope, academic anchoring, and policy-evaluation methods.

Broad incumbents

• Paris School of Economics (PSE): Co-founding parent institution and a much broader economics research powerhouse; Hospinnomics sits inside PSE and benefits from its doctoral programs and methodology, but PSE spans the full economics field.
• OECD Health Division: International policy body producing comparative health systems research, HTA, and pharmaceutical policy analysis — broader in geographic scope but methodologically adjacent to Hospinnomics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hospinnomics

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospinnomics